We are on CORDIS

June 28th, 2016 | Posted by SetLance in News

The article ''A new hope for treating severe pneumonia'' featuring Setlance's antimicrobial peptide M33 was published on CORDIS (Community Research and Development Information Service), the European Commission’s primary public repository and portal to disseminate information on EU-funded research projects.

Read the whole article here:




You can follow any responses to this entry through the RSS 2.0 Both comments and pings are currently closed.